C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study
about
Type 1 diabetesTreating human autoimmunity: current practice and future prospectsTopical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin.Clinical potential of antigen-specific therapies in type 1 diabetes.Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial.Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy.Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.Trials in type 1 diabetes: Antigen-specific therapies.Progress in immune-based therapies for type 1 diabetes.Clinical application of regulatory T cells in type 1 diabetes.Immune modulation in humans: implications for type 1 diabetes mellitus.Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.Combination immunotherapies for type 1 diabetes mellitus.The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.Current and future efforts toward the prevention of type 1 diabetes.Dead or alive?A rationally designed peptide IA-2-P2 against type 1 diabetes in streptozotocin-induced diabetic mice.Phases of type 1 diabetes in children and adolescents
P2860
Q27000491-5D5BA1EF-86FC-4012-A7DB-7C80F4BFE476Q33772444-448EC316-1137-4DB5-9F46-2A631EB70054Q36176416-59589E26-6D82-470A-8D77-021B3E1C3DC1Q37088212-FAC9678D-60F4-4A95-8D21-7E34F82C8379Q37251132-795734A1-622E-4125-96E5-490827CFE72DQ37969921-228B0402-D9A5-4165-83AF-87295C310D02Q38063547-0CE55CB4-85A1-42D3-BD0E-43605E6196CCQ38089387-51708BFF-C428-499F-8F65-D35B264D193EQ38097920-3C7B4D27-3AD2-4E98-AD4D-894B44AC3833Q38102783-18C50B97-9358-43A2-9EFE-04D94AB78A27Q38182297-06438713-9CC3-400B-8BB3-1EFEC428EAD5Q38236300-7BAE98DB-F6EF-44DE-84EC-F205A2017D80Q38358009-7F4CB276-764E-413B-9C6E-FD333F645F98Q38566913-C235E5D2-5ED9-4546-9E42-371250ADDA6CQ38842306-B01B147D-E4E6-4B1D-A567-21D3CD506C0CQ42552154-32B9DD44-3BC0-43CD-AD2E-13ACC2A47ED1Q50676922-F94B69F5-07BD-4D4A-BA03-2D5DF994DB6BQ57449039-CEA634D0-807C-4F6F-9602-912A2360FB52
P2860
C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@ast
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@en
type
label
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@ast
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@en
prefLabel
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@ast
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@en
P2093
P2860
P50
P356
P1433
P1476
C-peptide response and HLA gen ...... iaPep277: an exploratory study
@en
P2093
Antonio Petrone
Chiara Venditti
DiaPep Trialists Group
Marco Capizzi
Marialuisa Spoletini
Simona Cernea
Simona Zampetti
P2860
P304
P356
10.2337/DB10-0560
P407
P577
2011-09-06T00:00:00Z